Bryan Giraudo, Director at Protagonist Therapeutics, holds 23.13K shares in Protagonist Therapeutics (Ticker: PTGX), holds 480.01K shares in Gossamer Bio (Ticker: GOSS).

See the Hottest Stocks Based on Insider Trading >

Bryan Giraudo
Protagonist Therapeutics (PTGX)
Director

Ranked #3,417 out of 100,285 Corporate Insiders

Profitable Transactions

8 out of 15 Profitable Transactions

Average Return

+31.60%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

64.87%

PTGX

35.13%

GOSS

A breakdown of Bryan Giraudo's holdings

See the Top Stocks by Insiders

Insider Roles

Protagonist Therapeutics
(PTGX)

Director

Gossamer Bio
(GOSS)

COO/CFO

Roles that Bryan Giraudo holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Protagonist Therapeutics
(PTGX)

Rating:Informative Buy

Date:Dec 03, 2019 - Dec 03, 2020

Return:+354.10%

The most profitable trade made by Bryan Giraudo

See the Latest Stocks Traded by Insiders

Bryan Giraudo's Trading History

PTGX

Protagonist Therapeutics

Jan 06, 2025

Director

Uninformative Buy

―

$851.65K

GOSS

Gossamer Bio

Jun 20, 2024

COO/CFO

Informative Buy

59.00K

$461.29K

List of latest transactions for each holding click on a transaction to see Bryan Giraudo's performance on stock

See All Insider Trading from Today

Bryan Giraudo insider profile FAQ

What is the percentage of profitable transactions made by Bryan Giraudo?

The percentage of profitable transactions made by Bryan Giraudo is 53%.

What is the average return per transaction made by Bryan Giraudo?

The average return per transaction made by Bryan Giraudo is 31.60%.

What stocks does Bryan Giraudo hold?

Bryan Giraudo holds: PTGX, GOSS stocks.

What was Bryan Giraudo’s latest transaction?

Bryan Giraudo latest transaction was an Uninformative Buy of ―.

What was Bryan Giraudo's most profitable transaction?

Bryan Giraudo’s most profitable transaction was an Informative Buy of PTGX stock on December 3, 2019. The return on the trade was 354.10%.

What is Bryan Giraudo's role in Protagonist Therapeutics?

Bryan Giraudo's role in Protagonist Therapeutics is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Bryan Giraudo Insider Profile

Bryan Giraudo Protagonist Therapeutics (PTGX)Director